Moderna (MRNA) FCF Margin Growth (1y) (2019 - 2026)
Moderna (MRNA) FCF Margin Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,187.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,525.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -341.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Moderna | 22.52 Bn | 17.32 Bn | -566.00 Mn | 89,757.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 89,757.00 |
| Dec 31, 2025 | 4,798.00 |
| Sep 30, 2025 | -2,581.00 |
| Jun 30, 2025 | 626.00 |
| Mar 31, 2025 | -35,894.00 |
| Dec 31, 2024 | 8,120.00 |
| Sep 30, 2024 | 2,174.00 |
| Jun 30, 2024 | -34,049.00 |
| Mar 31, 2024 | -63,772.00 |
| Dec 31, 2023 | -2,864.00 |
| Sep 30, 2023 | -9,458.00 |
| Jun 30, 2023 | -26,680.00 |
| Mar 31, 2023 | -11,635.00 |
| Dec 31, 2022 | -1,440.00 |
| Sep 30, 2022 | -6,106.00 |
| Jun 30, 2022 | -8,917.00 |
| Mar 31, 2022 | -10,780.00 |
| Dec 31, 2021 | -16,646.00 |
| Sep 30, 2021 | -50,033.00 |
| Jun 30, 2021 | 13,111.00 |